HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.
about
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilityRET signaling is required for survival and normal function of nonpeptidergic nociceptorsSpinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.Acute exercise prevents the development of neuropathic pain and the sprouting of non-peptidergic (GDNF- and artemin-responsive) c-fibers after spinal cord injury.Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats.Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation.Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.Adenoviral-mediated glial cell line-derived neurotrophic factor gene transfer has a protective effect on sciatic nerve following constriction-induced spinal cord injury.Current gene therapy using viral vectors for chronic painHerpes simplex virus-based vectors.Gene expression in skin, muscle, and dorsal root ganglion after plantar incision in the rat.HSV trafficking and development of gene therapy vectors with applications in the nervous system.Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.Viral vector-based gene transfer for treatment of chronic pain.Gene therapy applications for the treatment of neuropathic pain.Herpes vector-mediated gene transfer in the treatment of chronic painApplications of gene therapy to the treatment of chronic pain.Targeted biological therapies for pain.Gene therapy for the treatment of chronic peripheral nervous system pain.Exercise after spinal cord injury as an agent for neuroprotection, regeneration and rehabilitation.Normalizing GDNF expression in the spinal cord alleviates cutaneous hyperalgesia but not ongoing pain in a rat model of bone cancer pain.Gene therapy: a potential approach for cancer pain.Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus.Pain research update from a genetic point of view.IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.HSV vector-mediated transduction and GDNF secretion from adipose cells.The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in ratsEssential role of Ret for defining non-peptidergic nociceptor phenotypes and functions in the adult mouse.Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors.
P2860
Q25257395-27BD34D4-DAF5-49CC-8607-3CD2F88DCC8AQ28081164-CB4A1D20-71E9-421A-8FE9-D50C6610821BQ28590500-457FDBB5-B1F1-4F9B-9AA7-705A7BFABA20Q33640240-E76408BA-C866-4B78-97BA-64BD9118B4C1Q33677694-75A10104-9947-4B84-BEB1-7AF9D4B461B5Q33712995-F7C0D809-8BCC-4A9D-A67D-FB70A9FB498EQ34062737-1C645BF4-5F0C-4501-ACC4-477B3572A86BQ34621676-C383808F-2799-469B-8F91-E4FF8D5E78FBQ35091885-F104BEFB-8513-455F-9FCA-381C9905A945Q35123977-4172D8D5-CCD2-4A42-85A4-E2F3EDD745C7Q35658521-291B4406-0C3C-4C64-82BA-A9F87B12F789Q35863367-CDF92C08-2EB0-44DD-BA09-C9FF2B22D630Q36075486-C414EEBE-B09F-48A3-81EA-35BBA23DDB2DQ36134871-33E43BCA-4723-4217-95DB-AE35B838CE95Q36274402-12B1A666-33BA-48F5-A21E-395474F97988Q36787828-BE8548D5-1A76-40BE-B353-0C0C6C5004B8Q36817045-09850830-98B1-4CAF-90C5-5C33D9B76ECCQ37035292-5A72D3BE-B3ED-4C70-89E3-0E5FFFD64A97Q37108334-8810AB42-DC99-40D7-B9D0-EF1281C67934Q37882724-1C573F56-693A-4519-9EBE-E0613A44BE1BQ38016275-BB398C0D-0969-45A8-9336-0FF0E03997C1Q38417759-D19F782F-E7BE-42DF-A0AD-841917E916ADQ38739366-197659A2-99CC-40AD-B9C6-3BC78ECF9DA0Q38745962-8C010791-7EDA-4DB4-B9C1-E433D7852F8CQ39967822-5EC3B53C-1AD1-4534-B0CA-44C2E375566AQ40259080-313231AD-EA7C-46B2-97C3-B5F5CDC5B81DQ40333178-7F4F508C-CC5A-4322-AEFC-4F089BEC7B3CQ40506805-12C05C73-822F-4B99-A266-A038AA8156E6Q42182469-DA4A5195-7C04-47F7-958F-D3DC7CB33680Q42485166-8F034763-FBA1-4BAC-B8F1-767919BA9425Q44086097-A029FE7B-7EF4-45ED-93D0-48B54EB42C21Q45874354-D988EF87-DA98-46CB-8129-E6C42BA2DB90Q45880904-0DF76B0C-C515-4D01-BA3A-73078A4C94F6
P2860
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
HSV-mediated gene transfer of ...... ic effect on neuropathic pain.
@en
type
label
HSV-mediated gene transfer of ...... ic effect on neuropathic pain.
@en
prefLabel
HSV-mediated gene transfer of ...... ic effect on neuropathic pain.
@en
P2093
P1433
P1476
HSV-mediated gene transfer of ...... ic effect on neuropathic pain.
@en
P2093
Darren Wolfe
David J Fink
Joseph C Glorioso
Marina Mata
Shaohua Huang
Shuanglin Hao
P304
P356
10.1016/S1525-0016(03)00185-0
P577
2003-09-01T00:00:00Z